WeVote

Bill

Bill

SB 220

State employee health plan coverage of Alzheimer's.

2025 Regular Session Introduced by Scott Baldwin and 5 co-sponsors

Indiana SB 220 mandates state employee health plans cover Alzheimer's disease treatments and therapies, expanding access but raising state budget costs and private sector coverage implications.

Senator Dernulc added as coauthor
0
WeVote Research Nonpartisan
Bill Summary · SB 220

Legislative bill overview

SB 220 requires Indiana's state employee health insurance plans to cover treatments and therapies for Alzheimer's disease and related dementias. The bill appears to mandate coverage expansion without imposing cost-sharing limitations that would prevent affected employees from accessing these services.

Why is this important

Alzheimer's and dementia affect approximately 120,000 Hoosiers, with costs often devastating to families. State employees and their dependents currently may face coverage gaps or high out-of-pocket costs for cognitive decline treatments, creating financial barriers to care. Expanding coverage could improve access to early interventions and management therapies while establishing a public sector precedent for private insurers.

Potential points of contention

  • Cost implications: Expanded coverage increases state health plan expenses, potentially requiring premium increases or budget reallocation from other programs during tight fiscal periods
  • Coverage scope ambiguity: The bill's definition of covered "treatments and therapies" remains unclear—whether it includes experimental drugs, behavioral therapies, long-term care support, or only FDA-approved medications
  • Private sector pressure: Mandating state plan coverage may create political pressure on private insurers to follow suit, potentially raising insurance costs statewide

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.